Does the dose of methotrexate influence the rate of relapse in patients with Wegener's granulomatosis?

Affiliations

Comment

Eamonn S Molloy et al. Nat Clin Pract Rheumatol. 2008 Jan.

. 2008 Jan;4(1):12-3.

doi: 10.1038/ncprheum0675.

¹ Center for Vasculitis Care and Research, Department of Rheumatic and Immunologic Diseases, Cleveland Clinic, Ohio 44195, USA.

No abstract available

Comment on

Elevated relapse rate under oral methotrexate versus leflunomide for maintenance of remission in Wegener's granulomatosis.
Metzler C, Miehle N, Manger K, Iking-Konert C, de Groot K, Hellmich B, Gross WL, Reinhold-Keller E; German Network of Rheumatic Diseases. Metzler C, et al. Rheumatology (Oxford). 2007 Jul;46(7):1087-91. doi: 10.1093/rheumatology/kem029. Epub 2007 May 22. Rheumatology (Oxford). 2007. PMID: 17519271 Clinical Trial.